Đang chuẩn bị liên kết để tải về tài liệu:
Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Neoadjuvant chemotherapy (NAC) has become the standard therapeutic option for early high-risk and locally advanced breast cancer. However, response rates to NAC vary between patients, causing delays in treatment and afecting the prognosis for patients who do not sensitive to NAC. |